Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Harr F. Njai"'
Autor:
Mario Lepore, Harr F. Njai, Deborah A. Garside, Yusuke Shimakawa, Mary M.E. Crossey, Ramou Njie, Maud Lemoine
Publikováno v:
South Sudan Medical Journal, Vol 8, Iss 2, Pp 33-35 (2015)
The Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study began in 2011 in The Gambia, Sénégal and Nigeria. The study aims to reduce the risk of hepatocellular carcinoma (HCC) in West Africa through the suppression of the Hepatitis B
Externí odkaz:
https://doaj.org/article/9d794dba812246bea87b1ebdcf2c0428
Autor:
Gibril Ndow, Erwan Vo Quang, Yusuke Shimakawa, Amie Ceesay, Saydiba Tamba, Harr F. Njai, Lamin Bojang, Charlotte Hateley, Yuki Takao, Emmanuel Opoke, Zakary Warsop, Maimuna Mendy, Umberto D’Alessandro, Patrick Ingiliz, Isabelle Chemin, Mark Thursz, Ramou Njie, Maud Lemoine
Publikováno v:
SSRN Electronic Journal.
Autor:
Mario Lepore, Harr F. Njai, Deborah A. Garside, Yusuke Shimakawa, Mary M.E. Crossey, Ramou Njie, Maud Lemoine
Publikováno v:
South Sudan Medical Journal; Vol 8, No 2 (2015); 33-35
South Sudan Medical Journal, Vol 8, Iss 2, Pp 33-35 (2015)
South Sudan Medical Journal, Vol 8, Iss 2, Pp 33-35 (2015)
The Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study began in 2011 in The Gambia, Sénégal and Nigeria. The study aims to reduce the risk of hepatocellular carcinoma (HCC) in West Africa through the suppression of the Hepatitis B
Autor:
Harr F Njai, Paul J Lewi, Cornelus GM Janssen, Sergio Garcia, Katrien Fransen, Luc Kestens, Guido Vanham, Paul AJ Janssen
Publikováno v:
Antiviral Therapy. 10:255-262
In order to study the inhibitory effect of various reverse transcriptase inhibitors (RTIs) on cell-free HIV, we adapted a recently described in vitro system, based on co-cultures of dendritic cells and resting CD4 T cells, modelling early target cell
Autor:
Maud Lemoine, PhD, Yusuke Shimakawa, PhD, Ramou Njie, PhD, Makie Taal, MSc, Gibril Ndow, MD, Isabelle Chemin, PhD, Sumantra Ghosh, PhD, Harr F Njai, PhD, Adam Jeng, BSc, Amina Sow, PhD, Prof. Coumba Toure-Kane, PhD, Prof. Souleymane Mboup, PhD, Penda Suso, BSc, Saydiba Tamba, Abdullah Jatta, Louise Sarr, MD, Aboubacar Kambi, MD, William Stanger, Bsc, Shevanthi Nayagam, MD, Jessica Howell, PhD, Liliane Mpabanzi, PhD, Prof. Ousman Nyan, MD, Prof. Tumani Corrah, PhD, Prof. Hilton Whittle, PhD, Prof. Simon D Taylor-Robinson, PhD, Prof. Umberto D'Alessandro, PhD, Maimuna Mendy, PhD, Prof. Mark R Thursz, MD
Publikováno v:
The Lancet Global Health, Vol 4, Iss 8, Pp e559-e567 (2016)
Background: Despite the introduction of immunisation for hepatitis B virus (HBV) in the 1990s, HBV-related morbidity and mortality remain high in sub-Saharan Africa. Identification and treatment of asymptomatic people with chronic HBV infection shoul
Externí odkaz:
https://doaj.org/article/81759de20466426494fc34e34db9ec6f
Autor:
Harr F Njai, Fiona M Ewings, Eric Lyimo, Vincent Foulongne, Dhamira Ngerageza, Aika Mongi, Deogratius Ssemwanga, Aura Andreasen, Balthazar Nyombi, Tony Ao, Denna Michael, Mark Urassa, Jim Todd, Basia Zaba, John Changalucha, Richard Hayes, Saidi H Kapiga
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e81848 (2013)
Increased understanding of the genetic diversity of HIV-1 is challenging but important in the development of an effective vaccine. We aimed to describe the distribution of HIV-1 subtypes in northern Tanzania among women enrolled in studies preparing
Externí odkaz:
https://doaj.org/article/9fc0ce7f8f7f43bebfe1207ced146b9b